Oxra-S 5/50mg (Dapagliflozin/Sitagliptin)

Previous product
Oxra-S 10/100mg (Dapagliflozin/Sitagliptin) $50.00 $160.00Price range: $50.00 through $160.00
Next product
Orgie Plus (Tadalafil/Dapoxetine) $50.00 $203.63Price range: $50.00 through $203.63

$50.00 $160.00Price range: $50.00 through $160.00

In Stock
In Stock

Oxra-S 5/50mg (Dapagliflozin/Sitagliptin)

Pack SizePricePrice / UnitQuantityAdd To Cart
60 Tablet/s$50.00$0.83 / Tablet
120 Tablet/s$90.00$0.75 / Tablet
240 Tablet/s$160.00$0.67 / Tablet
Want to order in bulk / B2B price? Send Inquiry
×

Sorry!! Out of Stock

View All Dapagliflozin/Sitagliptin Products
Clear

Offer You Can't Resist

Free Shipping

Enjoy Free Shipping on Orders above AUD304 (USD199)
Estimate Shipping :
11 June - 18 June
40
SKU: N/A Category:

What Our Customer Says

4.9
4.9 out of 5 stars (based on 187 reviews)

Fast dispatch

I have ordered multiple times and always receive excellent service. Fast dispatch, reliable tracking, and great support.

Australia Australia
May 21, 2026
Last Updated on May 05, 2026
Description

Introduction

Oxra-S 5/50mg is a combination medication that includes Dapagliflozin and Sitagliptin, two highly effective drugs used to manage type 2 diabetes. These medications work through different mechanisms, targeting multiple aspects of blood sugar control, which makes the combination especially beneficial for long-term diabetes management.

This guide explains its composition, mechanism of action, benefits, side effects, and frequently asked questions.

Associated condition: Type 2 Diabetes

What is Oxra-S 5/50mg?

Oxra-S 5/50mg is a fixed-dose combination medicine containing:

  • Dapagliflozin (5mg) – an SGLT2 inhibitor
  • Sitagliptin (50mg) – a DPP-4 inhibitor

This combination is prescribed when a single medication is not sufficient to control blood glucose levels.

Mechanism of Action

1. Dapagliflozin (SGLT2 Inhibitor)

  • Blocks the SGLT2 protein in the kidneys
  • Prevents glucose reabsorption
  • Promotes glucose excretion through urine

Result: Lower blood sugar levels without significantly increasing the risk of hypoglycemia.

2. Sitagliptin (DPP-4 Inhibitor)

  • Inhibits the DPP-4 enzyme
  • Increases incretin hormone levels
  • Enhances insulin release after meals
  • Reduces glucagon production

Result: Better control of post-meal blood sugar levels.

Benefits of Oxra-S 5/50mg

1. Improved Blood Sugar Control

The dual-action mechanism helps regulate glucose levels more effectively.

2. Reduced Risk of Hypoglycemia

Lower risk compared to insulin or sulfonylureas when used alone.

3. Weight Loss Support

Dapagliflozin promotes urinary calorie loss, leading to modest weight reduction.

4. Cardiovascular Benefits

May help reduce the risk of heart disease and related complications.

5. Convenience

A single tablet simplifies treatment and improves patient adherence.

How to Use Oxra-S 5/50mg

Typical Dosage:

  • One tablet once daily, as prescribed

Instructions:

  • Take with or without food
  • Swallow whole with water
  • Take at the same time each day

Important:

  • Do not exceed the recommended dose
  • Follow your doctor’s guidance strictly

Potential Side Effects

Common Side Effects:

  • Urinary tract infections
  • Genital infections
  • Increased urination
  • Thirst or dehydration
  • Nausea or mild stomach discomfort

Less Common:

  • Dizziness
  • Constipation

Rare but Serious:

  • Kidney problems
  • Diabetic ketoacidosis (DKA)
  • Pancreatitis
  • Severe allergic reactions

Seek immediate medical attention if serious symptoms occur.

Precautions and Warnings

  • Monitor kidney function regularly
  • Stay well hydrated
  • Use cautiously in elderly patients
  • Avoid during pregnancy and breastfeeding unless advised

Avoid if:

  • You have severe kidney disease
  • You have a history of ketoacidosis
  • You are allergic to its components

Who Should Consult a Doctor Before Use?

  • Patients with kidney or liver disorders
  • Individuals with cardiovascular conditions
  • Those taking other diabetes medications
  • Elderly patients

Conclusion

Oxra-S 5/50mg (Dapagliflozin/Sitagliptin) is an effective dual-action therapy for managing type 2 diabetes. By targeting different pathways, it improves blood sugar control, supports weight management, and may provide cardiovascular benefits.

Additional Information
Active Ingredient:

Dapagliflozin/Sitagliptin

Indication:

Type 2 Diabetes

Manufacturer:

Sun Pharmaceutical Industries Ltd.

Packaging:

15 Tablets in 1 Strip

Strength:

5mg/50mg

Delivery Time:

7 To 15 days

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Oxra-S 5/50mg (Dapagliflozin/Sitagliptin)”

Your email address will not be published. Required fields are marked *

Are you human? Please solve:Captcha